Early Access — free while we kick the tires
EdgarHawk

Mendelsohn Aaron

Director

Director
1 filing analyzed · 1 company · Latest 2025-12-31

Companies

Company Buys Sells Direction
Vivani Medical, Inc. VANI 2 0 Net buying

Activity

December 2025
2025-12-31 Vivani Medical, Inc. VANI
low
Buy
20,000 shares
$24,600
Significance 3/10

VANI Director Aaron Mendelsohn bought 20,000 shares at $1.23; stock down 34.2% from 52-week high amid -100.0% revenue decline.

Mendelsohn purchased 20,000 shares (20.0K shares) of VANI at $1.23 on 2025-12-29, increasing his holdings by 11.9%. The purchase occurs while the stock trades 34.2% below its 52-week high and after a 19.6% decline over 90 days. Fundamentals remain deeply challenged: the company reported zero revenue in its latest quarter, a -100.0% annual revenue decline, and a net loss of $6,530,000.00 ($-6.5M). Mendelsohn's prior buy at this same ticker on 2023-06-09 resulted in a 90-day loss of -28.4%, a pattern consistent with his broader cross-ticker track record which shows 0% win rate on 1 prior buy with an average 90-day return of -28.4%. The transaction occurs amid continued deterioration in the company's financial trajectory with no clear path to profitability visible in reported metrics.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access